ABVC Biopharma Operating Income Over Time
| ABVC Stock | USD 1.67 0.06 3.47% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out ABVC Biopharma Performance and ABVC Biopharma Correlation. Will Biotechnology sector continue expanding? Could ABVC diversify its offerings? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ABVC Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth 1.045 | Return On Assets | Return On Equity |
Understanding ABVC Biopharma requires distinguishing between market price and book value, where the latter reflects ABVC's accounting equity. The concept of intrinsic value - what ABVC Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ABVC Biopharma's price substantially above or below its fundamental value.
Understanding that ABVC Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ABVC Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, ABVC Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare ABVC Biopharma and related stocks such as Reviva Pharmaceuticals, Grace Therapeutics, and LAVA Therapeutics Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRCE | (1.5 M) | (6.6 M) | (6.8 M) | (9.7 M) | (9.9 M) | (7.1 M) | (15.3 M) | (15.3 M) | (34.4 M) | (24.4 M) | (16.4 M) | (15.6 M) | (52.2 M) | (11.3 M) | (16.7 M) | (15 M) | (15.8 M) |
| JUNS | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (1.9 M) | (3.9 M) | (3.4 M) | (3.9 M) | (3.1 M) | (2.8 M) | (2.9 M) |
| TVRD | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | (89.1 M) | (87.5 M) | (121.5 M) | (55.8 M) | (50.2 M) | (52.7 M) |
| LTRN | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (1.7 M) | (2.4 M) | (5.9 M) | (12.6 M) | (14.4 M) | (17.9 M) | (22.2 M) | (20 M) | (19 M) |
| XLO | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (19 M) | (54.6 M) | (75 M) | (89.1 M) | (79.1 M) | (60.6 M) | (54.5 M) | (57.2 M) |
ABVC Biopharma and related stocks such as Reviva Pharmaceuticals, Grace Therapeutics, and LAVA Therapeutics Operating Income description
Operating Income is the amount of profit realized from ABVC Biopharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of ABVC Biopharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| ABVC Biopharma | ABVC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 44370 Old Warm |
| Exchange | NASDAQ Exchange |
USD 1.67
Check out ABVC Biopharma Performance and ABVC Biopharma Correlation. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
ABVC Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.